As of June 30, 2026, Daewon Chemical Co., Ltd carries a market capitalization of 22.01B, placing it among publicly traded companies globally. Its enterprise value stands at 94.94B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 22.01B |
| Enterprise Value | 94.94B |
As of June 30, 2026, Daewon Chemical Co., Ltd has 8.15M shares outstanding.
| Shares Outstanding | 8.15M |
As of June 30, 2026, Daewon Chemical Co., Ltd trades at a trailing price-to-earnings ratio of 5.65. The price-to-sales ratio is 0.17, and the price-to-book ratio stands at 0.26.
| PE Ratio | 5.65 |
| PS Ratio | 0.17 |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.26 |
| P/FCF Ratio | -5.56 |
| P/OCF Ratio | -5.63 |
As of June 30, 2026, Daewon Chemical Co., Ltd trades at an EV/EBITDA multiple of 29.84 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.72 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 460.46 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 94.94B versus a market cap of 22.01B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.72 |
| EV / EBITDA | 29.84 |
| EV / EBIT | 460.46 |
As of June 30, 2026, Daewon Chemical Co., Ltd maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 96.51, indicating elevated leverage, while an interest coverage ratio of 0.70 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.84 |
| Quick Ratio | 0.08 |
| Debt / Equity | 96.51 |
| Debt / EBITDA | 25.74 |
| Interest Coverage | 0.70 |
Over the twelve months ended June 30, 2026, Daewon Chemical Co., Ltd posted a return on equity (ROE) of 6.32, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 2.22, measuring how efficiently the asset base is converted into earnings. The company generates approximately 1.55B in revenue per employee across its workforce of 85.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.78 indicates how many times Daewon Chemical Co., Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 6.32 |
| Return on Assets (ROA) | 2.22 |
| Revenue Per Employee | 1.55B |
| Employee Count | 85.25 |
| Inventory Turnover | 2.78 |
Over the twelve months ended June 30, 2026, Daewon Chemical Co., Ltd recorded an income tax benefit of -49.36M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -3.89B and 3.89B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -49.36M |
As of the close on October 23, 2026, Daewon Chemical Co., Ltd's stock has declined approximately 61.67% over the past 52 weeks. The 50-day moving average sits at 1,774.24, while the 200-day moving average is 3,179.79.
| 52-Week Price Change | -61.67% |
| 50-Day Moving Average | 1,774.24 |
| 200-Day Moving Average | 3,179.79 |
Over the twelve months ended June 30, 2026, Daewon Chemical Co., Ltd generated 131.88B in revenue and converted that into 3.89B in net income, yielding earnings per share of -471.72. EBITDA reached 3.18B, while operating income came in at 206.19M.
| Revenue | 131.88B |
| Gross Profit | 19.58B |
| Operating Income | 206.19M |
| Pretax Income | -3.89B |
| Net Income | 3.89B |
| EBITDA | 3.18B |
| EBIT | 206.19M |
| Earnings Per Share (EPS) | -471.72 |
As of June 30, 2026, Daewon Chemical Co., Ltd holds 9.01B in cash and equivalents against 81.88B in total debt, resulting in a net debt position of 68.34B. Total book value stands at 84.77B, with working capital of -17.25B providing operational flexibility.
| Cash & Cash Equivalents | 9.01B |
| Total Debt | 81.88B |
| Net Debt | 68.34B |
| Equity (Book Value) | 84.77B |
| Book Value Per Share | 10,399.17 |
| Working Capital | -17.25B |
Daewon Chemical Co., Ltd produced -3.90B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -49.89M in capital expenditures, free cash flow totaled -3.95B - equivalent to -485.60 per share.
| Operating Cash Flow | -3.90B |
| Capital Expenditures | -49.89M |
| Free Cash Flow | -3.95B |
| FCF Per Share | -485.60 |
Over the twelve months ended June 30, 2026, Daewon Chemical Co., Ltd posted a gross margin of 14.84, reflecting its pricing power and cost economics. The operating margin of 0.16 and net profit margin of 2.95 provide insight into operational efficiency.
| Gross Margin | 14.84 |
| Operating Margin | 0.16 |
| Pretax Margin | -2.95 |
| Profit Margin | 2.95 |
| EBITDA Margin | 2.41 |
Over the twelve months ended June 30, 2026, Daewon Chemical Co., Ltd paid dividends of 0.00 per share. The dividend payout ratio of -NaN indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -17.99: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.24, meaning Daewon Chemical Co., Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Payout Ratio | -NaN |
| Shareholder Yield | -2.24 |
| FCF Yield | -17.99 |
Daewon Chemical Co., Ltd's most recent stock split took place on May 21, 2026 with a 5:1 split ratio.
| Last Split Date | 5/21/2026 |
| Split Ratio | 5:1 |
As of June 30, 2026, Daewon Chemical Co., Ltd has an Altman Z-Score of 0.62, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.62 |
Already premium?